JP2015510880A5 - - Google Patents

Download PDF

Info

Publication number
JP2015510880A5
JP2015510880A5 JP2014560859A JP2014560859A JP2015510880A5 JP 2015510880 A5 JP2015510880 A5 JP 2015510880A5 JP 2014560859 A JP2014560859 A JP 2014560859A JP 2014560859 A JP2014560859 A JP 2014560859A JP 2015510880 A5 JP2015510880 A5 JP 2015510880A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
group
composition according
region
liver disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014560859A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015510880A (ja
Filing date
Publication date
Priority claimed from KR1020120024632A external-priority patent/KR101665009B1/ko
Application filed filed Critical
Publication of JP2015510880A publication Critical patent/JP2015510880A/ja
Publication of JP2015510880A5 publication Critical patent/JP2015510880A5/ja
Pending legal-status Critical Current

Links

JP2014560859A 2012-03-09 2013-03-08 非アルコール性脂肪肝疾患の予防または治療のための医薬組成物 Pending JP2015510880A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020120024632A KR101665009B1 (ko) 2012-03-09 2012-03-09 비알콜성 지방간 질환의 예방 또는 치료용 약학적 조성물
KR10-2012-0024632 2012-03-09
PCT/KR2013/001897 WO2013133667A1 (en) 2012-03-09 2013-03-08 Pharmaceutical composition for the prevention or treatment of non-alcoholic fatty liver disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017173062A Division JP2018009022A (ja) 2012-03-09 2017-09-08 非アルコール性脂肪肝疾患の予防または治療のための医薬組成物

Publications (2)

Publication Number Publication Date
JP2015510880A JP2015510880A (ja) 2015-04-13
JP2015510880A5 true JP2015510880A5 (cg-RX-API-DMAC7.html) 2017-06-01

Family

ID=49117073

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2014560859A Pending JP2015510880A (ja) 2012-03-09 2013-03-08 非アルコール性脂肪肝疾患の予防または治療のための医薬組成物
JP2017173062A Pending JP2018009022A (ja) 2012-03-09 2017-09-08 非アルコール性脂肪肝疾患の予防または治療のための医薬組成物
JP2019177304A Pending JP2019214627A (ja) 2012-03-09 2019-09-27 非アルコール性脂肪肝疾患の予防または治療のための医薬組成物
JP2021178501A Pending JP2022025114A (ja) 2012-03-09 2021-11-01 非アルコール性脂肪肝疾患の予防または治療のための医薬組成物

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2017173062A Pending JP2018009022A (ja) 2012-03-09 2017-09-08 非アルコール性脂肪肝疾患の予防または治療のための医薬組成物
JP2019177304A Pending JP2019214627A (ja) 2012-03-09 2019-09-27 非アルコール性脂肪肝疾患の予防または治療のための医薬組成物
JP2021178501A Pending JP2022025114A (ja) 2012-03-09 2021-11-01 非アルコール性脂肪肝疾患の予防または治療のための医薬組成物

Country Status (25)

Country Link
US (1) US20150056223A1 (cg-RX-API-DMAC7.html)
EP (1) EP2838549B1 (cg-RX-API-DMAC7.html)
JP (4) JP2015510880A (cg-RX-API-DMAC7.html)
KR (1) KR101665009B1 (cg-RX-API-DMAC7.html)
CN (2) CN104159597A (cg-RX-API-DMAC7.html)
AR (1) AR090287A1 (cg-RX-API-DMAC7.html)
AU (1) AU2013228152C1 (cg-RX-API-DMAC7.html)
CA (1) CA2864250C (cg-RX-API-DMAC7.html)
DK (1) DK2838549T3 (cg-RX-API-DMAC7.html)
ES (1) ES2900823T3 (cg-RX-API-DMAC7.html)
HK (1) HK1199220A1 (cg-RX-API-DMAC7.html)
HU (1) HUE057245T2 (cg-RX-API-DMAC7.html)
IL (1) IL234133B (cg-RX-API-DMAC7.html)
IN (1) IN2014DN06694A (cg-RX-API-DMAC7.html)
MX (2) MX2014010542A (cg-RX-API-DMAC7.html)
MY (1) MY167214A (cg-RX-API-DMAC7.html)
NZ (1) NZ628828A (cg-RX-API-DMAC7.html)
PH (1) PH12014501785B1 (cg-RX-API-DMAC7.html)
PL (1) PL2838549T3 (cg-RX-API-DMAC7.html)
PT (1) PT2838549T (cg-RX-API-DMAC7.html)
RU (1) RU2635966C2 (cg-RX-API-DMAC7.html)
SG (1) SG11201404733UA (cg-RX-API-DMAC7.html)
TW (2) TW201919688A (cg-RX-API-DMAC7.html)
WO (1) WO2013133667A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201405918B (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI601744B (zh) 2011-06-17 2017-10-11 韓美科學股份有限公司 包含調酸素與免疫球蛋白片段之複合物及其用途
KR101968344B1 (ko) 2012-07-25 2019-04-12 한미약품 주식회사 옥신토모듈린 유도체를 포함하는 고지혈증 치료용 조성물
EA039082B1 (ru) 2012-11-06 2021-12-01 Ханми Фарм. Ко., Лтд. Жидкая композиция белкового конъюгата, содержащего оксинтомодулин и фрагмент иммуноглобулина
MY186251A (en) 2014-01-20 2021-06-30 Hanmi Pharm Ind Co Ltd Long-acting insulin and use thereof
AR100639A1 (es) * 2014-05-29 2016-10-19 Hanmi Pharm Ind Co Ltd Composición para tratar diabetes que comprende conjugados de análogos de insulina de acción prolongada y conjugados de péptidos insulinotrópicos de acción prolongada
TWI684458B (zh) 2014-05-30 2020-02-11 南韓商韓美藥品股份有限公司 包含胰島素及glp-1/昇糖素雙重促效劑之治療糖尿病之組成物
TWI772252B (zh) 2014-09-16 2022-08-01 南韓商韓美藥品股份有限公司 長效glp-1/高血糖素受體雙促效劑治療非酒精性脂肝疾病之用途
KR102418477B1 (ko) 2014-12-30 2022-07-08 한미약품 주식회사 글루카곤 유도체
FI3322437T3 (fi) * 2015-06-30 2024-02-20 Hanmi Pharmaceutical Co Ltd Glukagonijohdannainen ja sen pitkävaikutteisen konjugaatin käsittävä koostumus
UY36870A (es) 2015-08-28 2017-03-31 Hanmi Pharm Ind Co Ltd Análogos de insulina novedosos
CN108136276B (zh) * 2015-09-24 2023-02-28 韩美药品株式会社 通过使用免疫球蛋白片段的特异性位点进行连接的蛋白质复合物
US20180360973A1 (en) * 2015-12-02 2018-12-20 Hanmi Pharm. Co., Ltd. Protein conjugate using a fatty acid derivative and method for preparation thereof
AU2017332408B2 (en) 2016-09-23 2022-02-10 Hanmi Pharm. Co., Ltd. Insulin analogs with reduced affinity to insulin receptor and use thereof
KR101906333B1 (ko) 2016-12-07 2018-10-11 고려대학교 산학협력단 지방간의 진단 또는 치료를 위한 류신 지퍼 단백질의 용도
KR101964743B1 (ko) 2017-01-19 2019-08-14 울산대학교 산학협력단 Gnpat을 유효성분으로 포함하는 비알콜성 지방간염 진단용 또는 치료 예후 예측용 바이오마커 조성물
WO2018174668A2 (ko) 2017-03-23 2018-09-27 한미약품 주식회사 인슐린 수용체와의 결합력이 감소된 인슐린 아날로그의 결합체 및 이의 용도
CN109248323B (zh) * 2017-07-14 2023-09-08 杭州先为达生物科技有限公司 酰化的glp-1衍生物
EP3437651A1 (en) * 2017-08-03 2019-02-06 Université de Strasbourg Peptides for treatment and prevention of nonalcoholic fatty liver disease
KR102174436B1 (ko) * 2017-08-17 2020-11-04 주식회사 엘지화학 불용성 안료 화합물의 정성분석방법
KR20200135618A (ko) 2019-05-23 2020-12-03 ㈜ 디앤디파마텍 폴리펩티드를 포함하는 비알코올성 지방간 질환의 예방 또는 치료용 약학 조성물
BR112021000933A2 (pt) * 2018-07-19 2021-04-27 D&D Pharmatech Inc. polipeptídeo, composição farmacêutica, método de preparação dela e método de prevenção ou tratamento de doenças
KR102177304B1 (ko) * 2018-07-23 2020-11-10 제이투에이치바이오텍 (주) 비알콜성 지방간염의 예방 또는 치료용 약학 조성물
CN110151980B (zh) * 2019-06-30 2022-12-09 中国药科大学 Glp-1受体激动剂融合蛋白在制备预防或治疗高血脂药物中的应用
KR102315866B1 (ko) * 2020-03-24 2021-10-21 한국원자력의학원 섬유화 질환 복합 치료제 개발

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5545618A (en) 1990-01-24 1996-08-13 Buckley; Douglas I. GLP-1 analogs useful for diabetes treatment
US5424686A (en) 1994-04-20 1995-06-13 Philips Electronics North America Corporation Negative-resistance-compensated microwave buffer
US6096871A (en) 1995-04-14 2000-08-01 Genentech, Inc. Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life
CA2249195A1 (en) 1996-03-18 1997-09-25 Board Of Regents, The University Of Texas System Immunoglobin-like domains with increased half lives
KR101135244B1 (ko) * 2007-11-29 2012-04-24 한미사이언스 주식회사 인슐린 분비 펩타이드 결합체를 포함하는 비만 관련질환 치료용 조성물
US8263084B2 (en) * 2003-11-13 2012-09-11 Hanmi Science Co., Ltd Pharmaceutical composition for treating obesity-related disease comprising insulinotropic peptide conjugate
EP1689700A1 (en) * 2003-11-25 2006-08-16 Novo Nordisk A/S Novel salicylic anilides
US8389472B2 (en) * 2005-08-19 2013-03-05 Amylin Pharmaceuticals, Llc Exendin-4 to treat nonalcoholic steatohepatitis and nonalcoholic fatty liver disease
JP2008169195A (ja) * 2007-01-05 2008-07-24 Hanmi Pharmaceutical Co Ltd キャリア物質を用いたインスリン分泌ペプチド薬物結合体
WO2008108439A1 (ja) * 2007-03-06 2008-09-12 Bridgestone Corporation ゴムクローラ
US8315710B2 (en) * 2008-07-11 2012-11-20 Medtronic, Inc. Associating therapy adjustments with patient posture states
EP2300501B1 (en) * 2008-07-23 2014-08-20 Hanmi Science Co., Ltd. A polypeptide complex comprising non-peptidyl polymer having three functional ends
EP2248449A1 (en) * 2009-05-08 2010-11-10 Koninklijke Philips Electronics N.V. Kitchen appliance
WO2011109787A1 (en) * 2010-03-05 2011-09-09 Conjuchem, Llc Methods of administering insulinotropic peptides
KR101382593B1 (ko) * 2010-07-21 2014-04-10 한미사이언스 주식회사 신규한 지속형 글루카곤 결합체 및 이를 포함하는 비만 예방 및 치료용 약학적 조성물

Similar Documents

Publication Publication Date Title
JP2022025114A5 (cg-RX-API-DMAC7.html)
RU2014133615A (ru) Фармацевтическая композиция для предупреждения или лечения неалкогольной жировой болезни печени
KR102434280B1 (ko) 옥신토모듈린과 면역글로불린 단편을 포함하는 단백질 결합체의 액상 제제
KR102762409B1 (ko) 지속형 glp-1/글루카곤 수용체 듀얼 아고니스트의 비알콜성 지방간질환에 대한 용도
JP2015503554A5 (cg-RX-API-DMAC7.html)
JP6903086B2 (ja) オキシントモジュリン誘導体を含む高脂血症の治療のための組成物
JP2017529354A5 (cg-RX-API-DMAC7.html)
NZ585314A (en) A pharmaceutical composition for treating obesity-related disease comprising insulinotropic peptide conjugate
RU2015138536A (ru) Новый аналог инсулина и его применение
JP2015536943A5 (cg-RX-API-DMAC7.html)
WO2009075859A3 (en) Formulation of insulinotropic peptide conjugates
RU2009129953A (ru) Инсулинотропный комплекс, в котором использован фрагмент иммуноглобулина
RU2012146663A (ru) Конъюгат инсулина с применением фрагмента иммуноглобулина
JP2019524675A5 (cg-RX-API-DMAC7.html)
CA2890329A1 (en) A composition for treating diabetes or diabesity comprising oxyntomodulin analog
WO2008000516A3 (en) IMPROVED sgp130Fc DIMERS
JP2013533875A5 (cg-RX-API-DMAC7.html)
NZ727871B2 (en) Composition for treating diabetes mellitus comprising insulin and a glp-1/glucagon dual agonist
NZ724926A (en) Method for improving solubility of protein and peptide by using immunoglobulin fc fragment linkage
NZ750267A (en) Glucagon derivative, conjugate thereof, composition comprising same and therapeutic use thereof
NZ750267B2 (en) Glucagon derivative, conjugate thereof, composition comprising same and therapeutic use thereof
BR112017004934B1 (pt) Composição farmacêutica para a prevenção ou tratamento de inflamação hepática, e uso de um conjugado de agonista duplo do receptor de glp-1/glucagon de ação prolongada
HK1147958A (en) Formulation of insulinotropic peptide conjugates
HK1211856B (en) A composition for treating diabetes or diabesity comprising oxyntomodulin analog